| Ki |
- |
| EC50 |
|
| IC50 |
|
| Inhibition |
50.27%(Aβ1-40 aggregation, 100μM), 20.23%(Aβ1-40 aggregation, 50μM) |
| Toxicity |
|
| ROS(reactive oxygen species) |
|
| Metal Chelating |
|
| BBB(blood-brain barrier) |
|
| Target Protein |
Aβ1-40 |
| Effects |
Prevent Aβ-induced AD-associated pathological changes in vitro and in vivo, significantly inhibited auto- and AChE-induced aggregation of Aβ1–40 in vitro and blocked the cell death induced by Aβ1–40 in PC12 cells, in an AD mouse model by the intracerebroventricular injection of Aβ1–40, T6FA significantly improved the cognitive ability along with increasing choline acetyltransferase and superoxide dismutase activity, decreasing AChE activity and malondialdehyde level |
| Research Models |
In vivo, in vitro, in PC12 cells, in AD mouse |
| Ref. Link |
|